GlassScriptPhysician profile
Rolando D Breier
NPI 1033379938
$4,351.12
in general payments reported to CMS, 2019-2025
44 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $158 · 2021: $624 · 2022: $708 · 2023: $888 · 2024: $820 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473 · Education: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,473.13 |
| Education | $255.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $354.44 | 2021-2025 | |
| Seagen INC. | $337.82 | 2019-2023 | Padcev, Tukysa, Adcetris |
| Merck Sharp & Dohme LLC | $303.31 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $244.77 | 2021-2025 | Carvykti, Darzalex, Tecvayli |
| Incyte Corporation | $230.69 | 2020-2025 | Monjuvi, Pemazyre, Jakafi |
| Lilly USA, LLC | $220.26 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Astrazeneca Pharmaceuticals LP | $196.77 | 2021-2025 | Enhertu, Imfinzi, Calquence |
| Amgen INC. | $190.64 | 2020-2023 | Lumakras, Kyprolis, Blincyto |
| Pfizer INC. | $185.74 | 2019-2025 | |
| Eisai INC. | $173.85 | 2020-2025 | |
| Genzyme Corporation | $150.35 | 2021-2025 | |
| Tersera Therapeutics LLC | $146.01 | 2021-2024 | Zoladex |
| E.R. Squibb & Sons, L.L.C. | $120.63 | 2020-2024 | Opdualag, Opdivo |
| Astellas Pharma US INC | $106.50 | 2019-2025 | Padcev, Xtandi |
| Sanofi-Aventis U.S. LLC | $99.99 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Breier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.